Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:827-829
Published online before print March 27, 2006, doi: 10.1161/01.HYP.0000215283.53943.39
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/827    most recent
01.HYP.0000215283.53943.39v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lévy, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lévy, B. I.
Related Collections
Right arrow Other heart failure
Right arrow Angiogenesis
Right arrow Myocardial cardiomyopathy disease
Right arrowRelated Article

(Hypertension. 2006;47:827.)
© 2006 American Heart Association, Inc.


Editorial Commentaries

Microvascular Plasticity and Experimental Heart Failure

Bernard I. Lévy

From the Centre for Cardiovascular Research, Inserm Lariboisière, Paris, France.

Correspondence to Bernard Lévy, Centre for Cardiovascular Research, Inserm U689, 41 Bd de la Chapelle, 75010 Paris, France. E-mail levy@larib.inserm.fr


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Angiogenesis is an essential process in adulthood during wound healing and restoration of blood flow to injured tissues. Angiogenesis is regulated by a very sensitive interplay of growth factors and inhibitors; their imbalance can lead to very diverse diseases. Excessive angiogenesis is involved in malignant, diabetic retinopathy and inflammatory disorders (eg, rheumatoid arthritis, psoriasis, atherosclerosis). Conversely, insufficient angiogenesis may underlie conditions such as ischemic heart diseases, stroke, hypertension, and diabetes. Hence, during the evolution of these degenerative pathologies, inadequate blood vessel growth and insufficient microvascular density leads to poor circulation and tissue suffering or, ultimately, necrosis and death.1

In several physiological conditions, such as muscular exercise training and detraining, acclimatization to altitude, and aging, an adaptation of the microvascular network structure and function to new conditions has been reported.2,3 Interestingly, there is a close link between cerebral angiogenesis and learning; during cognitive decline in relation to senescence or degenerative cerebral diseases, microvascular density is decreased in specific cerebral areas. Specifically, there is a striking relationship between the capillary density, the cerebral tissue blood flow, the local glucose use, and other measures of neuronal signaling, such as the NA+/K+ ATPase (reviewed in Reference 4). Therefore, microvascular plasticity, defined as the ability of the arteriole and capillary network to adapt to the metabolic local conditions by proangiogenesis or antiangiogenesis processes, likely plays a key role in many tissue homeostatic processes.


*    Microvasculature and Arterial Hypertension
 
In hypertension, the role of microcirculation (arteriolar and capillary) is of particular importance in increasing periph-eral resistance by decreasing the number . . . [Full Text of this Article]


Related Article:

Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload
Yasuhiro Izumiya, Ichiro Shiojima, Kaori Sato, Douglas B. Sawyer, Wilson S. Colucci, and Kenneth Walsh
Hypertension 2006 47: 887-893. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
R. Iliescu, S. R. Fernandez, S. Kelsen, C. Maric, and A. R. Chade
Role of renal microcirculation in experimental renovascular disease
Nephrol. Dial. Transplant., November 23, 2009; (2009) gfp605v1.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
X.-Y. Zhu, E. Daghini, A. R. Chade, C. Napoli, E. L. Ritman, A. Lerman, and L. O. Lerman
Simvastatin Prevents Coronary Microvascular Remodeling in Renovascular Hypertensive Pigs
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1209 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Schiekofer, I. Shiojima, K. Sato, G. Galasso, Y. Oshima, and K. Walsh
Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure
Physiol Genomics, October 11, 2006; 27(2): 156 - 170.
[Abstract] [Full Text] [PDF]